Editorial Policy
Periods
The present Environment Report covers results achieved during the period of the fiscal year 2020 (from April 1, 2020 through March 31, 2021) in Japan and the calendar year 2020 (from January 1 through December 31, 2020) outside Japan. The report also covers our activities conducted immediately before or after these periods.
Organizations
The report covers the environmental activities of Shionogi & Co., Ltd. and the Shionogi Group companies in the table below. Sections of the report that concern a different set of organizations are clearly indicated as such in each instance.
As a change from the previous year, UMN Pharma Inc. is included as a Shionogi Group company. With regard to the Nanjing Plant of C&O Pharmaceutical Technology (Holdings) Limited, a non-Japanese Shionogi Group company and manufacturing base, the relevant data, excluding data on climate change, are disclosed separately from those of the Shionogi Group under “Site Data.”
| Category | Companies/Operating sites | |
|---|---|---|
Shionogi & Co., Ltd. (referred to as “Shionogi” in the report) |
Head Office | Shionogi CMC Research Innovation Center (Hyogo Prefecture) ＊1 |
| Tokyo Branch Office (Tokyo) | Shionogi Pharmaceutical Research Center (SPRC) |
|
| Pharmaceutical Commercial Division (including its sales offices across Japan) |
Aburahi Research Center (Shiga Prefecture)＊2 | |
| Group companies | Shionogi Healthcare Co., Ltd. | |
| Shionogi Pharma Co., Ltd. Settsu Plant, Kanegasaki Plant (Iwate Prefecture) Tokushima Plant (Tokushima Prefecture) |
||
| Shionogi Techno Advance Research Co., Ltd.＊3 | ||
| Shionogi Administration Service Co., Ltd. | ||
| Shionogi Business Partner Co., Ltd. | ||
| Shionogi Marketing Solutions Co., Ltd.＊3 | ||
| Shionogi Career Development Center Co., Ltd. (Hyogo Prefecture) | ||
| Shionogi Digital Science Co., Ltd. | ||
| Shionogi Pharmacovigilance Center Co., Ltd.＊3 | ||
| Aburahi AgroResearch Co., Ltd. (Shiga Prefecture)＊3 | ||
| Shionogi Smile Heart Co., Ltd.＊3 | ||
| UMN Pharma Inc. (Akita Prefecture, Kanagawa Prefecture)＊4 | ||
| C&O Pharmaceutical Technology（Holdings）Limited (Nanjing Plant, China) | ||
The companies and operating sites with no indication of location are all situated in Osaka Prefecture.
＊1 Formerly Kuise Site, the name was changed on April 1, 2020.
＊2 Formerly Aburahi Facilities, the name was changed on April 1, 2020.
＊3 Located on the premises of Shionogi & Co., Ltd.
＊4 As of December 19, 2019, it became a consolidated subsidiary.
Numerical data and graphs
The numerical data provided in the report are obtained by rounding off digits smaller than the units indicated. Accordingly, the actual sums of the individual figures in the graphs and charts do not necessarily correspond to the total figures in the same graphs and charts.
Environmental performance data related to energy and CO2
Although the emission factors specified in-house had been used for target progress management until the FY2019 results, the data has been calculated based on the following calculation methods for FY2020 results and afterwards. At the same time, the data for the previous years have been revised.
Calculation methods for environmental performance data
Boundary of calculation
| Scope 1 and 2: | Shionogi Group (excluding overseas subsidiaries [administrative offices]): Shionogi Group companies in Japan (Nagase Medicals Co., Ltd. is not included in the calculation for fiscal 2020) and the Nanjing Plant of C&O Pharmaceutical Technology (Holdings) Limited |
| Scope 3 | |
| Category 3: | Shionogi Group companies in Japan (Shionogi & Co., Ltd. in or before fiscal 2018) (Nagase Medicals Co., Ltd. is not included in the calculation for fiscal 2020) |
| Other category | Shionogi Group companies in Japan (Shionogi & Co., Ltd. in or before fiscal 2018) (UMN Pharma, Inc. and Nagase Medicals Co., Ltd. are not included in the calculation for fiscal 2020) |
| Energy consumption: | Shionogi Group (excluding overseas subsidiaries [administrative offices]): Shionogi Group companies in Japan (Nagase Medicals Co., Ltd. is not included in the calculation for fiscal 2020) and the Nanjing Plant of C&O Pharmaceutical Technology (Holdings) Limited |
Calculation methods
| Indicators | Calculation methods |
|---|---|
| Scope 1 | CO2 emissions resulting from fuel use Calculation methods: Based on the “Greenhouse Gas Emissions Accounting and Reporting Manual (Ver. 4.7)” of the Ministry of the Environment and the Ministry of Economy, Trade and Industry of Japan |
| Scope 2 | CO2 emissions resulting from purchase of electricity and steam Calculation methods: Based on the “Greenhouse Gas Emissions Accounting and Reporting Manual (Ver. 4.7)” of the Ministry of the Environment and the Ministry of Economy, Trade and Industry of Japan |
| Scope 3 | |
| Category 3 | CO2 emissions resulting from procurement of fuels required for the generation of electricity purchased Calculation methods: Based on the “Basic Guidelines on Accounting for Greenhouse Gas Emissions Throughout the Supply Chain (Ver. 2.3)” of the Ministry of the Environment and the Ministry of Economy, Trade and Industry of Japan, calculated using “7. Emission Unit Values per Use of Electricity and Heat” in the “The Database on Emissions Unit Values for Calculation of Greenhouse Gas Emissions, etc., by Organizations Throughout the Supply Chain (Ver. 3.1)” of the Ministry of the Environment of Japan |
| Other categories | Total of Categories 1, 2, 4, 5, 6, 7 and 12, excluding Categories 8, 9, 10, 11, 13, 14 and 15 that are not included in our own corporate activities or are reported under other categories Calculation methods: Based on the “Basic Guidelines on Accounting for Greenhouse Gas Emissions Throughout the Supply Chain (Ver.2.3)” of the Ministry of the Environment and the Ministry of Economy, Trade and Industry of Japan |
| Energy consumption | |
| Total energy consumption | Total calorie-converted values for purchased energy (gasoline, other fuel oils, LPG, LNG, town gas, electricity, steam) Calculation methods: Based on the Regulations for Enforcement of the Act on the Rational Use of Energy Calorie conversion factors: Based on the Regulations for Enforcement of the Act on the Rational Use of Energy |
| Gasoline | Amount of gasoline purchased, including fuel for sales force vehicles |
| Other fuel oils | Amount of kerosene, light oil, heavy oil A purchased |
| Liquefied petroleum gas (LPG) | Amount of LPG purchased from gas suppliers |
| Liquefied natural gas (LNG) | Amount of LNG purchased from gas suppliers |
| Town gas | Amount of town gas purchased from gas suppliers |
| Electricity | Amount of electricity purchased from power suppliers |
| Steam | Amount of steam purchased from steam suppliers |
Reporting guidelines
Overall reporting view
A copy of this report is made available on Shionogiʼs official website, while excerpts from the report are included in SHIONOGI Integrated Report.
The environmental data of FY 2020 marked with a red check on Page 94 of “SHIONOGI Integrated Report 2021,” published separately from the present report, was subjected to third-party assurance by KPMG AZSA Sustainability Co., Ltd.
Trends of major performance assessment indicators
